More about Science

Choose a therapeutic area to find related scientific content

Diabetes

Dyslipedimia

Neurology

Oncology

Rare Blood Disorders

Rare Diseases

Thrombosis

Explore Content

Explore the most recently added content

Prescribing Information can be found through the links in the Product Cards at the bottom of the page

 

Support for your Patients

Discover the selection of support materials for patients from different therapeutic areas

Our Products

ALDURAZYME
laronidase

Prescribing Information UK

MAT-XU-2200954 (v1.0)
Date of preparation: September 2022
 

AUBAGIO
teriflunomide

Prescribing Information GB
Prescribing Information NI

MAT-XU-2200676 (v3.0)
Date of preparation: August 2022

Cablivi
caplacizumab

Prescribing Information GB
Prescribing Information NI

MAT-GB-2105168 (v2.0)
Date of preparation: November 2022

CERDELGA
eliglustat 84mg

Prescribing Information UK  

MAT-XU-2204064 (v1.0)
Date of preparation: September 2022

CEREZYME
imiglucerase

Prescribing Information UK

MAT-XU-2204065 (v1.0)
Date of preparation: September 2022

FABRAZYME
agalsidase beta

Prescribing Information UK

MAT-GB-2105812 (v2.0)
Date of preparation: August 2022

LEMTRADA
Alemtuzumab

Prescribing Information GB
Prescribing Information NI

MAT-XU-2200680 (v2.0)
Date of preparation: August 2022

MYOZYME
alglucosidase alfa

Prescribing Information UK

MAT-GB-2105179 (v3.0)
Date of preparation: August 2022

Praluent
alirocumab


Prescribing Information GB
Prescribing Information NI

 

MAT-XU-2204604 (v1.0)
Date of preparation: October 2022

▼ This drug is subject to additional monitoring, the reporting of suspected adverse reactions associated with this drug is a priority.

MAT-GB-2105264 (v4.0) ​​​​​​
Date of preparation: December 2022